Table of Contents
Chapter 1. Executive Summary
Chapter 2. Methodology and Scope
2.1. Research methodology
2.2. Assumptions
2.3. List of data sources
Chapter 3. Introduction
3.1. Stable Isotope Ratio Mass Spectrometer
Chapter 4. Global Stable Isotope Ratio Mass Spectrometer Market Trends: Drivers & Opportunities
4.1. Introduction
4.2. Key industry trends
4.2.1. Raw material trend
4.2.2. Technology trend
4.2.3. Supplier trend
4.2.4. Buyer trend
4.2.5. Regulatory trend
4.3. Market drivers
4.4. Market restraints
4.5. Opportunity Assessment
4.6. Value chain analysis
4.7. PESTEL Analysis
4.8. Qualitative Analysis on Distribution Strategies
4.9. Porter's Five Forces analysis
4.10. SWOT
Chapter 5. Stable Isotope Ratio Mass Spectrometer (IRMS) Market Trends, By Type
5.1. Global Stable Isotope Ratio Mass Spectrometer market movement, by product, 2016 & 2024
5.1.1. GC-Isotope Ratio Mass Spectrometer
5.1.1.1. Market estimates and forecast, 2014 - 2024 (USD Million)
5.1.2. EA-Isotope Ratio Mass Spectrometer
5.1.2.1. Market estimates and forecast, 2014 - 2024 (USD Million)
5.1.3. LC-Isotope Ratio Mass Spectrometer
5.1.3.1. Market estimates and forecast, 2014 - 2024 (USD Million)
Chapter 6. Stable Isotope Ratio Mass Spectrometer (IRMS) Market Trends, By End user
6.1. Global Stable Isotope Ratio Mass Spectrometer market movement, by indication, 2016 & 2024
6.1.1. Research
6.1.1.1. Market estimates and forecast, 2014 - 2024 (USD Million)
6.1.2. Commercial
6.1.2.1. Market estimates and forecast, 2014 - 2024 (USD Million)
Chapter 7. Global Stable Isotope Ratio Mass Spectrometer Market Trends, By Region
7.1. Global Stable Isotope Ratio Mass Spectrometer market movement, by region, 2016 & 2024
7.1.1. North America
7.1.1.1. Market estimates and forecast, 2014 - 2024 (USD Million)
7.1.1.2. Market estimates and forecast, by type, 2014 - 2024 (USD Million)
7.1.1.3. Market estimates and forecast, by end user, 2014 - 2024 (USD Million)
7.1.2. Europe
7.1.2.1. Market estimates and forecast, 2014 - 2024 (USD Million)
7.1.2.2. Market estimates and forecast, by type, 2014 - 2024 (USD Million)
7.1.2.3. Market estimates and forecast, by end user, 2014 - 2024 (USD Million)
7.1.3. Asia-Pacific
7.1.3.1. Market estimates and forecast, 2014 - 2024 (USD Million)
7.1.3.2. Market estimates and forecast, by type, 2014 - 2024 (USD Million)
7.1.3.3. Market estimates and forecast, by end user, 2014 - 2024 (USD Million)
7.1.4. Rest of the World (RoW)
7.1.4.1. Market estimates and forecast, 2014 - 2024 (USD Million)
7.1.4.2. Market estimates and forecast, by type, 2014 - 2024 (USD Million)
7.1.4.3. Market estimates and forecast, by end user, 2014 - 2024 (USD Million)
Chapter 8. Key Country Markets
8.1. U.S.
8.1.1. Market estimates and forecast, 2014 - 2024 (USD Million)
8.1.2. Market estimates and forecast, by type, 2014 - 2024 (USD Million)
8.1.3. Market estimates and forecast, by end user, 2014 - 2024 (USD Million)
8.2. Germany
8.2.1. Market estimates and forecast, 2014 - 2024 (USD Million)
8.2.2. Market estimates and forecast, by type, 2014 - 2024 (USD Million)
8.2.3. Market estimates and forecast, by end user, 2014 - 2024 (USD Million)
8.3. U.K.
8.3.1. Market estimates and forecast, 2014 - 2024 (USD Million)
8.3.2. Market estimates and forecast, by type, 2014 - 2024 (USD Million)
8.3.3. Market estimates and forecast, by end user, 2014 - 2024 (USD Million)
8.4. China
8.4.1. Market estimates and forecast, 2014 - 2024 (USD Million)
8.4.2. Market estimates and forecast, by type, 2014 - 2024 (USD Million)
8.4.3. Market estimates and forecast, by end user, 2014 - 2024 (USD Million)
8.5. India
8.5.1. Market estimates and forecast, 2014 - 2024 (USD Million)
8.5.2. Market estimates and forecast, by type, 2014 - 2024 (USD Million)
8.5.3. Market estimates and forecast, by end user, 2014 - 2024 (USD Million)
Chapter 9. Competitive Landscape
9.1. Company market share, 2016
9.2. Strategic framework
9.3. Company profiles
9.3.1. Thermo Fisher Scientific Inc.
9.3.1.1. Company Overview
9.3.1.2. Financial Performance
9.3.1.3. Product Benchmarking
9.3.1.4. SWOT
9.3.1.5. Recent Initiatives
9.3.1.6. Future Outlook and Strategies
9.3.2. Los Gatos Research, Inc.
9.3.2.1. Company Overview
9.3.2.2. Financial Performance
9.3.2.3. Product Benchmarking
9.3.2.4. SWOT
9.3.2.5. Recent Initiatives
9.3.2.6. Future Outlook and Strategies
9.3.3. Aerodyne Research Inc.
9.3.3.1. Company Overview
9.3.3.2. Financial Performance
9.3.3.3. Product Benchmarking
9.3.3.4. SWOT
9.3.3.5. Recent Initiatives
9.3.3.6. Future Outlook and Strategies
9.3.4. Elementar Analysensysteme GmbH
9.3.4.1. Company Overview
9.3.4.2. Financial Performance
9.3.4.3. Product Benchmarking
9.3.4.4. SWOT
9.3.4.5. Recent Initiatives
9.3.4.6. Future Outlook and Strategies
9.3.5. Sercon Group
9.3.5.1. Company Overview
9.3.5.2. Financial Performance
9.3.5.3. Product Benchmarking
9.3.5.4. SWOT
9.3.5.5. Recent Initiatives
9.3.5.6. Future Outlook and Strategies
9.3.6. CAMECA
9.3.6.1. Company Overview
9.3.6.2. Financial Performance
9.3.6.3. Product Benchmarking
9.3.6.4. SWOT
9.3.6.5. Recent Initiatives
9.3.6.6. Future Outlook and Strategies
9.3.7. Picarro Inc.
9.3.7.1. Company Overview
9.3.7.2. Financial Performance
9.3.7.3. Product Benchmarking
9.3.7.4. SWOT
9.3.7.5. Recent Initiatives
9.3.7.6. Future Outlook and Strategies
9.3.8. Ionplus AG
9.3.8.1. Company Overview
9.3.8.2. Financial Performance
9.3.8.3. Product Benchmarking
9.3.8.4. SWOT
9.3.8.5. Recent Initiatives
9.3.8.6. Future Outlook and Strategies
9.3.9. Sidomuncul
9.3.9.1. Company Overview
9.3.9.2. Financial Performance
9.3.9.3. Product Benchmarking
9.3.9.4. SWOT
9.3.9.5. Recent Initiatives
9.3.9.6. Future Outlook and Strategies
9.3.10. Nature Herbs
9.3.10.1. Company Overview
9.3.10.2. Financial Performance
9.3.10.3. Product Benchmarking
9.3.10.4. SWOT
9.3.10.5. Recent Initiatives
9.3.10.6. Future Outlook and Strategies
Research Support Specialist, USA
steve@hexaresearch.com